WO2000012760A3 - Toxicological response markers - Google Patents

Toxicological response markers Download PDF

Info

Publication number
WO2000012760A3
WO2000012760A3 PCT/US1999/019768 US9919768W WO0012760A3 WO 2000012760 A3 WO2000012760 A3 WO 2000012760A3 US 9919768 W US9919768 W US 9919768W WO 0012760 A3 WO0012760 A3 WO 0012760A3
Authority
WO
WIPO (PCT)
Prior art keywords
response markers
toxicological response
composition
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/019768
Other languages
French (fr)
Other versions
WO2000012760A2 (en
Inventor
Mary Jane Cunningham
Gary B Zweiger
Scott R Panzer
Jeffrey J Seilhamer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/141,825 external-priority patent/US6403778B1/en
Priority claimed from US09/172,108 external-priority patent/US6160104A/en
Priority claimed from US09/172,711 external-priority patent/US6160105A/en
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to EP99968250A priority Critical patent/EP1108067A2/en
Priority to AU60222/99A priority patent/AU6022299A/en
Priority to CA002340589A priority patent/CA2340589A1/en
Priority to JP2000567743A priority patent/JP2002523112A/en
Publication of WO2000012760A2 publication Critical patent/WO2000012760A2/en
Publication of WO2000012760A3 publication Critical patent/WO2000012760A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to a composition comprising a plurality of nucleic acid molecules. The composition can be used as hybridizable array elements in a microarray. The present invention also relates to methods for screening compounds and therapeutics for metabolic responses indicative of a toxic compound.
PCT/US1999/019768 1998-08-28 1999-08-27 Toxicological response markers Ceased WO2000012760A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99968250A EP1108067A2 (en) 1998-08-28 1999-08-27 Toxicological response markers
AU60222/99A AU6022299A (en) 1998-08-28 1999-08-27 Toxicological response markers
CA002340589A CA2340589A1 (en) 1998-08-28 1999-08-27 Toxicological response markers
JP2000567743A JP2002523112A (en) 1998-08-28 1999-08-27 Toxicological markers

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/141,825 1998-08-28
US09/141,825 US6403778B1 (en) 1998-05-04 1998-08-28 Toxicological response markers
US09/172,108 US6160104A (en) 1998-10-13 1998-10-13 Markers for peroxisomal proliferators
US09/172,108 1998-10-13
US09/172,711 US6160105A (en) 1998-10-13 1998-10-13 Monitoring toxicological responses
US09/172,711 1998-10-13

Publications (2)

Publication Number Publication Date
WO2000012760A2 WO2000012760A2 (en) 2000-03-09
WO2000012760A3 true WO2000012760A3 (en) 2000-08-03

Family

ID=27385714

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/019768 Ceased WO2000012760A2 (en) 1998-08-28 1999-08-27 Toxicological response markers

Country Status (5)

Country Link
EP (1) EP1108067A2 (en)
JP (1) JP2002523112A (en)
AU (1) AU6022299A (en)
CA (1) CA2340589A1 (en)
WO (1) WO2000012760A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798392B1 (en) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa GENETIC MARKERS OF TOXICITY, PREPARATION AND USES
WO2002008453A2 (en) * 2000-07-21 2002-01-31 Phase-1 Molecular Toxicology Canine toxicity genes
US7590493B2 (en) 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
EP1364049A2 (en) * 2000-07-31 2003-11-26 Gene Logic, Inc. Molecular toxicology modeling
EP1368499A2 (en) * 2001-01-29 2003-12-10 Phase-1 Molecular Toxicology Inc. Rat toxicologically relevant genes and uses thereof
EP1392871A4 (en) 2001-05-22 2006-04-19 Gene Logic Inc MOLECULAR TOXICOLOGY MODELING
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
JPWO2003014394A1 (en) * 2001-08-03 2004-11-25 旭メディカル株式会社 Biocompatibility evaluation method
US20050112573A1 (en) * 2001-08-24 2005-05-26 Hitoshi Iwahashi Method of detecting toxic substance
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
EP1344834A3 (en) * 2002-03-14 2004-06-02 F. Hoffmann-La Roche Ag Methods for the toxicity prediction of a compound
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
WO2004058957A2 (en) * 2002-12-31 2004-07-15 Pharmacia & Upjohn Company Llc Canine cyp1a2 sequences

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020681A1 (en) * 1994-01-27 1995-08-03 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020681A1 (en) * 1994-01-27 1995-08-03 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL embl heidelberg; 30 September 1995 (1995-09-30), LEE H.N. ET AL.,: "EST108960 rat PC-12 cells", XP002130308 *
LEE N.H. ET AL.,: "Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment", PROC. NATL. ACAD. SCI. USA, vol. 92, - August 1995 (1995-08-01), pages 8303 - 8307, XP002047703 *
SCHENA M ET AL: "PARALLEL HUMAN GENOME ANALYSIS: MICROARRAY-BASED EXPRESSION MONITORING OF 1000 GENES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 93, no. 20, 1 October 1996 (1996-10-01), pages 10614 - 10619, XP002912238, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1108067A2 (en) 2001-06-20
JP2002523112A (en) 2002-07-30
CA2340589A1 (en) 2000-03-09
AU6022299A (en) 2000-03-21
WO2000012760A2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
WO2000012760A3 (en) Toxicological response markers
CA2336634A1 (en) Antiviral macrocyclic compounds
AU2003228649A1 (en) Compositions and methods related to two-arm nucleic acid probes
IL141567A0 (en) Fluorescence polarization in nucleic acid analysis
GB2346214B (en) Analysis of single nucleotide polymorphisms using mass spectrometry
IL208340A0 (en) Compositions and processes for detecting qualitative or quantitatively the presence of a nucleic acid of interest
WO2001004314A3 (en) Nucleic acid molecules and proteins associated with sterol synthesis and metabolism
WO2003006625A8 (en) Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
CA2412967A1 (en) Sequencing method
AU2001276843A1 (en) Nucleic acid enzyme biosensor for ions
WO2002038806A3 (en) Detection of nucleic acid polymorphisms
WO2003064605A3 (en) Crude biological derivatives competent for nucleic acid detection
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
AU1121001A (en) Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
NO982176D0 (en) Corrosion Inhibited Organic Acid Compositions and Methods for Using Them
Stenersen et al. Earthworms for toxicity testing; species differences in response towards cholinesterase inhibiting insecticides
WO2002002740A3 (en) Methods and compositions for determining gene function
ID26395A (en) GAMMA-AMINOBUTIRAT ACID DEPOSIT CONTAINING SOLID COMPOSITION AND THE PROCESS OF MAKING
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
WO2006017549A3 (en) Cell-based kinase assay
AU2003303588A1 (en) Methods and compositions for sequencing nucleic acid molecules
ID28810A (en) AMIDA-OMEGA ACID N-ARILSULFONILAMINO COMPOUNDS
ATE420963T1 (en) POLYNUCLEOTIDE CONSTRUCTS AND USES THEREOF
WO2004001015A3 (en) Method for sequencing nucleic acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2340589

Country of ref document: CA

Ref country code: CA

Ref document number: 2340589

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 567743

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999968250

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999968250

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999968250

Country of ref document: EP